Teladoc Health, Inc.TDOCEarnings & Financial Report
Teladoc Health, Inc. is a multinational telemedicine and virtual healthcare company headquartered in New York, New York, United States that was founded in 2002. Primary services include telehealth, medical opinions, AI and analytics, telehealth devices and licensable platform services. In particular, Teladoc Health uses telephone and videoconferencing software as well as mobile apps to provide on-demand remote medical care.
TDOC Q1 FY2026 Key Financial Metrics
Revenue
$613.8M
Gross Profit
N/A
Operating Profit
$-61.8M
Net Profit
$-63.8M
Gross Margin
N/A
Operating Margin
-10.1%
Net Margin
-10.4%
YoY Growth
-2.5%
EPS
$-0.36
Teladoc Health, Inc. Q1 FY2026 Financial Summary
Teladoc Health, Inc. reported revenue of $613.8M (down 2.5% YoY) for Q1 FY2026, with a net profit of $-63.8M (up 31.4% YoY) (-10.4% margin).
Key Financial Metrics
| Total Revenue | $613.8M |
|---|---|
| Net Profit | $-63.8M |
| Gross Margin | N/A |
| Operating Margin | -10.1% |
| Report Period | Q1 FY2026 |
Revenue Breakdown
Teladoc Health, Inc. Q1 FY2026 revenue of $613.8M breaks down across 2 segments, led by U.S at $491.5M (80.1% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| U.S | $491.5M | 80.1% |
| International | $122.3M | 19.9% |
Teladoc Health, Inc. Annual Revenue by Year
Teladoc Health, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $2.5B).
Teladoc Health, Inc. Quarterly Revenue & Net Profit History
Teladoc Health, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $613.8M | -2.5% | $-63.8M | -10.4% |
| Q4 FY2025 | $642.3M | +0.3% | N/A | N/A |
| Q3 FY2025 | $626.4M | -2.2% | $-49.5M | -7.9% |
| Q2 FY2025 | $631.9M | -1.6% | $-32.7M | -5.2% |
| Q1 FY2025 | $629.4M | -2.6% | $-93.0M | -14.8% |
| Q4 FY2024 | $640.5M | -3.0% | N/A | N/A |
| Q3 FY2024 | $640.5M | -3.0% | $-33.3M | -5.2% |
| Q2 FY2024 | $642.4M | -1.5% | $-837.7M | -130.4% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $642.4M | $640.5M | $640.5M | $629.4M | $631.9M | $626.4M | $642.3M | $613.8M |
| YoY Growth | -1.5% | -3.0% | -3.0% | -2.6% | -1.6% | -2.2% | 0.3% | -2.5% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $3.52B | $3.53B | $3.52B | $3.44B | $2.89B | $2.88B | $2.86B | $2.81B |
| Liabilities | $2.02B | $2.02B | $2.03B | $2.02B | $1.47B | $1.49B | $1.47B | $1.47B |
| Equity | $1.50B | $1.51B | $1.49B | $1.43B | $1.42B | $1.39B | $1.39B | $1.34B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $88.7M | $110.2M | $85.9M | $15.9M | $91.4M | $99.3M | $87.7M | $9.5M |